Pharmacology in Biological Products
Navigation Links
Pharmacology in Biological Products
Prostaglandin E1-d4 from Cayman Chemical
Description:... metabolite of dihomo-γ-linolenic acid (DGLA), but it is virtually undetectable in the plasma of normal humans or other animals. Its pharmacology includes vasodilation, hypotension, and anti-platelet activities. The IC50 of PGE1 for the inhibition of ADP-induced human platelet aggregation is 40 ...Company:Cayman Chemical
hKvLQT1/hminK-CHO K1 Recombinant Cell Line from Upstate
Description:... objective is to provide the pharmaceutical industry with a range of ion channel cell lines to support drug discovery, lead optimisation and safety pharmacology ....Company:Upstate
hNav1.6-HEK293 Recombinant Cell Line from Upstate
Description:... objective is to provide the pharmaceutical industry with a range of ion channel cell lines to support drug discovery, lead optimisation and safety pharmacology ....Company:Upstate
hKv1.5-CHO K1 Recombinant Cell Line from Upstate
Description:... objective is to provide the pharmaceutical industry with a range of ion channel cell lines to support drug discovery, lead optimisation and safety pharmacology ....Company:Upstate
hHCN4-CHO K1 Recombinant Cell Line from Upstate
Description:... objective is to provide the pharmaceutical industry with a range of ion channel cell lines to support drug discovery, lead optimisation and safety pharmacology ....Company:Upstate
hERG-CHO K1 Recombinant Cell Line from Upstate
Description:... objective is to provide the pharmaceutical industry with a range of ion channel cell lines to support drug discovery, lead optimisation and safety pharmacology functions. Mycoplasma Testing: The cell line has been screened using the PCR VenorGem kit (Minerva Biolabs) to confirm the absence of Mycoplasma ...Company:Upstate
hERG-CHO K1 Recombinant Cell Line from Upstate
Description:... objective is to provide the pharmaceutical industry with a range of ion channel cell lines to support drug discovery, lead optimisation and safety pharmacology ....Company:Upstate
hKv4.2/hKChIP2-CHO K1 Recombinant Cell Line from Upstate
Description:... objective is to provide the pharmaceutical industry with a range of ion channel cell lines to support drug discovery, lead optimisation and safety pharmacology ....Company:Upstate
Other Contentsphotosystemphotosystemalgaalgaalgaphylogeneticsphylogeneticsphylogenyphylogenyphylogenytreetreetreetreetreetreephylogeneticphylogeneticphylogeneticphylogeneticpigmentpigmentpigmentpigmentpigment
Breaking Biology News(10 mins):$2.4 million stimulus fuels effort to regenerate injured spinal cords 2$2.4 million stimulus fuels effort to regenerate injured spinal cords 3$2.4 million stimulus fuels effort to regenerate injured spinal cords 4AACR names Perou 2009 Outstanding Investigator for Breast Cancer Research 2Delivering medicine directly into a tumor 2MathMagic Personal 4 8 for Windows Now Supports Google Docs and Zoho Equation 62592 1MathMagic Personal 4 8 for Windows Now Supports Google Docs and Zoho Equation 62592 2MathMagic Personal 4 8 for Windows Now Supports Google Docs and Zoho Equation 62592 3MathMagic Personal 4 8 for Windows Now Supports Google Docs and Zoho Equation 62592 4IntelliSoft Group Focuses on Protecting Customer Investment in Medical Credentialing Systems Budget Constraints and Forced Upgrades in Medical Cred 62589 1IntelliSoft Group Focuses on Protecting Customer Investment in Medical Credentialing Systems Budget Constraints and Forced Upgrades in Medical Cred 62589 2The Chopra Center for Wellbeing Launches Vedamune 3A An Ayurvedic Supplement to Support The Immune System 62586 1The Chopra Center for Wellbeing Launches Vedamune 3A An Ayurvedic Supplement to Support The Immune System 62586 2
Breaking Medicine News(10 mins):Health News:Beckman Coulter to Host Annual Business Review 2Health News:Researchers identify barriers to HPV vaccination uptake in low-income populations 2Health News:Researchers identify barriers to HPV vaccination uptake in low-income populations 3Health News:Orlando Company Develops New Technology Designed To Help Combat Hospital-Acquired Infections 2Health News:Orlando Company Develops New Technology Designed To Help Combat Hospital-Acquired Infections 3Health News:Securities Class Action Filed by Shepherd, Finkelman, Miller & Shah, LLP on Behalf of Hemispherx Biopharma Securities Purchasers Between February 18, 2009 and November 2, 2009 2Health News:Securities Class Action Filed by Shepherd, Finkelman, Miller & Shah, LLP on Behalf of Hemispherx Biopharma Securities Purchasers Between February 18, 2009 and November 2, 2009 3Health News:Securities Class Action Filed by Shepherd, Finkelman, Miller & Shah, LLP on Behalf of Hemispherx Biopharma Securities Purchasers Between February 18, 2009 and November 2, 2009 4Health News:New National Study Spotlights Importance of Federal Medicare Funding to Propping-Up Seniors' Deteriorating State Medicaid Benefits and Services 2Health News:New National Study Spotlights Importance of Federal Medicare Funding to Propping-Up Seniors' Deteriorating State Medicaid Benefits and Services 3
Other TagsLDFEmboEmboEmboDopDopDopDopDopDopDopOther Tagsviolations 2cross 2cross 3cross 4cross 5cross 6red 2red 3red 4red 5red 6red 7red 8red 9red 10pinpoint 2pinpoint 3pinpoint 4pinpoint 5[0] Beckman Coulter to Host Annual Business Review[0] Researchers identify barriers to HPV vaccination uptake in low-income populations[0] Orlando Company Develops New Technology Designed To Help Combat Hospital-Acquired Infections[0] Securities Class Action Filed by Shepherd, Finkelman, Miller & Shah, LLP on Behalf of Hemispherx Biopharma Securities Purchasers Between February 18, 2009 and November 2, 2009[0] New National Study Spotlights Importance of Federal Medicare Funding to Propping-Up Seniors' Deteriorating State Medicaid Benefits and Services
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |